<DOC>
	<DOCNO>NCT00759018</DOCNO>
	<brief_summary>This protocol allow treatment pediatric patient , male female , age 2 month 17 year . Patients must fail steroid treatment Grade B-D acute GVHD .</brief_summary>
	<brief_title>Prochymal Expanded Access Treatment Pediatric Patients Who Have Failed Steroids Acute GVHD</brief_title>
	<detailed_description>For treatment pediatric patient fail respond steroid treatment acute graft-versus-host disease ( GVHD ) . Failing steroid treatment acute GVHD define Grade B-D ( IBMTR grade ) acute GVHD improve least 3 day methylprednisolone ( â‰¥ 1 mg/kg/day ) equivalent . Patients treat Prochymal twice per week dose 2 x 10^6 hMSC/kg ( actual body weight ) 4 consecutive week . Infusions administer least 3 day apart .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Patients must 2 month 17 year age , inclusive Patients fail respond steroid treatment Grades BD acute GVHD Patient must know allergy bovine porcine product Patient must receive transplant solid tumor disease . Patient must evidence pulmonary infiltrate diffuse alveolar hemorrhage likely require 2L oxygen via face mask estimate FiO2 28 % via delivery method order sustain O2 saturation 92 % next 3 day .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>GVHD</keyword>
	<keyword>Prochymal</keyword>
	<keyword>Graft v Host Disease</keyword>
</DOC>